5 TH MARCH NEW PATENTS

END FEB, start march 2018

11 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	EP-03287467	OBETICHOLIC ACID	RATIOPHARM	Liver disease; Primary biliary cirrhosis
2	WO-2018039521	CENICRIVIROC	CONCERT	Bladder cancer; HIV infection; Head and neck tumor; Hodgkins disease; Melanoma;
3	WO-2018038680	OLAPARIB	SCINOPHARM	Breast tumor; Fallopian tube cancer;
4	WO-2018038426	EDOXABAN	DONG	Deep vein thrombosis
5	WO-2018037423	FLUNISOLIDE	CORAL	Allergic rhinitis; Inflammatory disease
6	WO-2018037350	LUMACAFTOR	LAURUS	Cystic fibrosis
7	WO-2018037124	AVIBACTAM	SANDOZ	ANTIBACTERIAL
8	WO-2018036982	URSODEOXYCHOLIC ACID	PHARMAZELL	Cholelithiasis; Hepatitis;
9	WO-2018036558	DAROLUTAMIDE	CRYSTAL	Hormone dependent prostate cancer;
10	WO-2018036557	LENALIDOMIDE	ZHEJIANG	Adult T-cell lymphoma; Mantle cell lymphoma; Myelodysplastic syndrome
11	WO-2018036416	EFINACONAZOLE	TROPHARMAN	Fungal infection; Onychomycosis

NEW PATENTS FEB 2018

New patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018033631	MARIZOMIB	CELGENE	CANCER
2	WO-2018034901	ELAMIPRETIDE	STEALTH	Barth syndrome; Mitochondrial myopathy
3	WO-2018033866	SACUBITRIL, VALSARTAN	NOVARTIS	CARDIAC FAILURE, HYPERTENSION
4	WO-2018033149	OZANIMOD	CRYSTAL	Multiple sclerosis; Ulcerative colitis
5	WO-2018033139	SOFOSBUVIR	CHIA	Hepatitis C virus infection
6	WO-2018032521	LIRAGLUTIDE	SHENZEN	Non-insulin dependent diabetes; Obesity
7	WO-2018032356	SOFOSBUVIR	PHARMARESOURCES	Hepatitis C virus infection
8	WO-2018032796	SITAFLOXACIN	CHEN-STONE	Bacterial infection
9	WO-2018033939	BUDESONIDE	ANANTCO	Allergic rhinitis; Inflammatory bowel disease; Irritable bowel syndrome

 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	EP-03281941	LESINURAD	ZENTIVA	Gout; Hyperuricemia
2	WO-2018029711	VENETOCLAX	MYLAN	Chronic lymphocytic leukemia
3	WO-2018029699	BELINIOSTAT	MSN	Hematological neoplasm; Solid tumor
4	WO-2018029264	DAPAGLIFLOZIN	AMNEAL	Non-insulin dependent diabetes
5	WO-2018029223	GALETERONE	INDUSTRIALE	PROSTRATE TUMOR
6	WO-2018028508	PIRFENIDONE	IND	Idiopathic pulmonary fibrosis
7	WO-2018028506	PIRFENIDONE	IND	Idiopathic pulmonary fibrosis
8	WO-2018029611	DAPAGLIFLOZIN	LAURUS	Non-insulin dependent diabetes
9	WO-2018028420	PLINABULIN	QUINGDAO	CANCER
10	WO-2018028679	MIRABEGRON	ZHEJIANG	Overactive bladder